Kuniaki  Ogasawara

Prof. Kuniaki Ogasawara

Department of Neurosurgery, Iwate Medical University, 1-1-1 Idaidori, Yahaba, 028-3694 Iwate, Japan
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2022 in International Journal of Stroke
Verified
Journal Article
Open access
SMSusumu Miyamoto
Susumu Miyamoto
KOKuniaki Ogasawara
Kuniaki Ogasawara
SKSatoshi Kuroda
Satoshi Kuroda
RIRyo Itabashi
Ryo Itabashi
KTKazunori Toyoda
Kazunori Toyoda
WKWataru Kakuda
Wataru Kakuda
The revised Japan Stroke Society Guidelines for the Treatment of Stroke were published in Japanese in July 2021. In this article, the extracted recommendation statements are published. The revision keeps pace with the great progress in stroke control based on the recently enacted Basic Act on Stroke and Cardiovascular Disease in Japan. The guideline covers the following areas: primary prevention, general acute management of stroke, ischemic stroke and transient ischemic attack, intracerebral hemorrhage, subarachnoid hemorrhage, asymptomatic cerebrovascular disease, other cerebrovascular disease, and rehabilitation.

1 July 2002 in Stroke
Verified
Journal Article
Open access
PDF file
KOKuniaki Ogasawara
Kuniaki Ogasawara
AOAkira Ogawa
Akira Ogawa
TYTakashi Yoshimoto
Takashi Yoshimoto
Background and Purpose — The present study prospectively evaluated relationships among baseline characteristics, cerebral hemodynamics, and outcome of patients with symptomatic major cerebral artery occlusion, by quantitative measurement of cerebral blood flow using xenon-133 ( 133 Xe) inhalation and single-photon emission computed tomography (SPECT). Methods — Regional cerebrovascular reactivity (rCVR) to acetazolamide was calculated at entry to the study using 133 Xe SPECT. Seventy consecutive patients aged less than 70 years with unilateral internal carotid artery (ICA) or middle cerebral artery (MCA) occlusion were divided into 2 groups: normal or reduced rCVR, and prospectively followed up for a period of 24 months. Results — During the follow-up period, recurrent strokes occurred in 8 of the 23 patients with reduced rCVR at entry and in 3 of 47 patients with normal rCVR. Cumulative recurrence-free survival rates in all patients, and in each subgroup of patients with ICA or MCA occlusion and reduced rCVR on entry, were significantly lower than in those with normal rCVR ( P =0.0030, P =0.0404, and P =0.0310, respectively; Kaplan-Meier analysis). Among the factors considered, only lower rCVR and resting regional cerebral blood flow values were significantly associated with the risk of stroke recurrence ( P =0.0019 and P =0.0080, respectively; Cox regression multivariate analysis). Conclusions — The present study demonstrated that reduced rCVR to acetazolamide as determined by 133 Xe SPECT is significantly associated with an increased risk of stroke recurrence in patients with symptomatic MCA or ICA occlusion.

1 September 2003 in Journal of Neurosurgery
Verified
Journal Article
Closed access
KOKuniaki Ogasawara
Kuniaki Ogasawara
HYHirotsugu Yukawa
Hirotsugu Yukawa
MKMasakazu Kobayashi
Masakazu Kobayashi
CMChiaki Mikami
Chiaki Mikami
HKHiromu Konno
Hiromu Konno
AOAkira Ogawa
Akira Ogawa
Object. The purpose of this study was to determine whether the preoperative measurement of acetazolamide-induced changes in cerebral blood flow (CBF), which is performed using single-photon emission computerized tomography (SPECT) scanning, can be used to identify patients at risk for hyperperfusion following carotid endarterectomy (CEA). In addition, the authors investigated whether monitoring of CBF with SPECT scanning after CEA can be used to identify patients at risk for hyperperfusion syndrome. Methods. Cerebral blood flow and cerebrovascular reactivity (CVR) to acetazolamide were measured before CEA in 51 patients with ipsilateral internal carotid artery stenosis (≥ 70% stenosis). Cerebral blood flow was also measured immediately after CEA and on the 3rd postoperative day. Hyperperfusion (an increase in CBF of ≥ 100% compared with preoperative values) was observed immediately after CEA in eight of 12 patients with reduced preoperative CVR. Reduced preoperative CVR was the only significant independent predictor of post-CEA hyperperfusion. Forty-three patients in whom hyperperfusion was not detected immediately after CEA did not exhibit hyperperfusion on the 3rd postoperative day and did not experience hyperperfusion syndrome. In two of eight patients in whom hyperperfusion occurred immediately after CEA, CBF progressively increased and hyperperfusion syndrome developed, but intracerebral hemorrhage did not occur. In the remaining six of eight patients in whom hyperperfusion was detected immediately after CEA, the CBF progressively decreased and the hyperperfusion resolved by the 3rd postoperative day. Conclusions. Preoperative measurement of acetazolamide-induced changes in CBF, which is performed using SPECT scanning, can be used to identify patients at risk for hyperperfusion after CEA. In addition, post-CEA monitoring of CBF performed using SPECT scanning results in the timely and reliable identification of patients at risk for hyperperfusion syndrome.

5 January 2021 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
AHAtsushi Hozawa
Atsushi Hozawa
KTKozo Tanno
Kozo Tanno
NNNaoki Nakaya
Naoki Nakaya
TNTomohiro Nakamura
Tomohiro Nakamura
NTNaho Tsuchiya
Naho Tsuchiya
MYMasayuki Yamamoto
Masayuki Yamamoto
BackgroundWe established a community-based cohort study to assess the long-term impact of the Great East Japan Earthquake on disaster victims and gene-environmental interactions on the incidence of major diseases such as cancer and cardiovascular diseases.MethodsWe asked participants to join our cohort in the health check-up settings and assessment center based settings. Inclusion criteria was aged 20 years or over and living in Miyagi or Iwate Prefecture. We obtained information on lifestyle, effect of disaster, blood, and urine information (Type 1 survey), and some detailed measurements (Type 2 survey), for example, carotid echography, calcaneal ultrasound bone mineral density, and so on. All participants agreed to measure genome information and to distribute their information widely.ResultsAs a result, 87,865 gave their informed consent to join our study. Participation rate at health check-up site was about 70%. The participants with Type 1 survey were more likely to have psychological distress than those of Type 2 survey, and women were more likely to have psychological distress than men. Additionally, coastal residents were more likely to have higher degrees of psychological distress than inland residents regardless of sex.ConclusionThis cohort comprised large sample size and it contains information on disaster, genome information, and metabolome information. This cohort also had several detailed measurements. Using this cohort enabled us to clarify the long-term effect of disaster and also to establish personalized prevention based on genome, metabolome, and other omics information.

1 November 2004 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
KOKuniaki Ogasawara
Kuniaki Ogasawara
TITakashi Inoue
Takashi Inoue
MKMasakazu Kobayashi
Masakazu Kobayashi
HEHidehiko Endo
Hidehiko Endo
TFTakeshi Fukuda
Takeshi Fukuda
AOAkira Ogawa
Akira Ogawa
OBJECTIVE: Cerebral hyperperfusion syndrome after carotid endarterectomy (CEA) is a rare but potentially devastating complication. The purpose of the present study, which was not a randomized controlled trial but a case cohort study with historical control, was to determine whether pretreatment with a novel free radical scavenger, edaravone, could prevent occurrence of cerebral hyperperfusion after CEA. METHODS: Fifty patients with ipsilateral internal carotid artery stenosis (≥70%) underwent CEA with administration of edaravone before internal carotid artery clamping. Preoperative cerebral blood flow and cerebrovascular reactivity (CVR) to acetazolamide were assessed with single-photon emission computed tomography (SPECT). Cerebral blood flow also was measured immediately after CEA and on the 3rd postoperative day. RESULTS: Cerebral hyperperfusion (cerebral blood flow increase ≥100% compared with preoperative values) was revealed by SPECT performed immediately after CEA in only one patient (2%), who also exhibited reduced preoperative CVR. The incidence of post-CEA hyperperfusion as revealed by SPECT in the control group (51 CEA patients without administration of edaravone) was significantly higher (16%) (P= 0.0310, control versus treatment group). In addition, in a subgroup of patients with reduced preoperative CVR, the incidence of post-CEA hyperperfusion as revealed by SPECT in the edaravone group (7%) was significantly lower than that in the control group (67%) (P= 0.0029). Logistic regression analysis demonstrated that reduced preoperative CVR and absence of pretreatment with edaravone were significant independent predictors of post-CEA hyperperfusion as revealed by SPECT. CONCLUSION: Pretreatment with edaravone can prevent occurrence of cerebral hyperperfusion after CEA.

1 August 2003 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
KOKuniaki Ogasawara
Kuniaki Ogasawara
HKHiromu Konno
Hiromu Konno
HYHirotsugu Yukawa
Hirotsugu Yukawa
HEHidehiko Endo
Hidehiko Endo
TITakashi Inoue
Takashi Inoue
AOAkira Ogawa
Akira Ogawa
OBJECTIVE. Hyperperfusion syndrome is a rare but potentially devastating complication that can occur after carotid endarterectomy (CEA). The purpose of